ACSM1
Basic information
Region (hg38): 16:20623235-20698890
Previous symbols: [ "BUCS1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (83 variants)
- not_provided (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACSM1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001318890.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 74 | 83 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 74 | 11 | 1 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACSM1 | protein_coding | protein_coding | ENST00000307493 | 13 | 75654 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.28e-15 | 0.207 | 125497 | 0 | 251 | 125748 | 0.000999 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.204 | 320 | 330 | 0.968 | 0.0000182 | 3740 |
Missense in Polyphen | 120 | 130.81 | 0.91733 | 1552 | ||
Synonymous | 0.640 | 116 | 125 | 0.927 | 0.00000684 | 1116 |
Loss of Function | 1.21 | 27 | 34.7 | 0.779 | 0.00000189 | 358 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00302 | 0.00302 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000925 | 0.000925 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.00106 | 0.00106 |
Middle Eastern | 0.000925 | 0.000925 |
South Asian | 0.000361 | 0.000359 |
Other | 0.00147 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: Has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). Acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4- unsaturated acids (in vitro). Functions as GTP-dependent lipoate- activating enzyme that generates the substrate for lipoyltransferase (By similarity). {ECO:0000250}.;
- Pathway
- Butanoate metabolism - Homo sapiens (human);Valproic Acid Pathway, Pharmacokinetics;Phenylacetate Metabolism;Valproic Acid Metabolism Pathway;Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids;Butyrate Metabolism;Valproic acid pathway;chrebp regulation by carbohydrates and camp;Butanoate metabolism;Conjugation of benzoate with glycine;Conjugation of phenylacetate with glutamine;Conjugation of carboxylic acids;Amino Acid conjugation;Phase II - Conjugation of compounds;Biological oxidations;Metabolism;γ-linolenate biosynthesis;Butanoate metabolism;icosapentaenoate biosynthesis II (metazoa)
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- 0.973
- rvis_EVS
- 0.12
- rvis_percentile_EVS
- 62.17
Haploinsufficiency Scores
- pHI
- 0.0238
- hipred
- N
- hipred_score
- 0.145
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.541
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acsm1
- Phenotype
Gene ontology
- Biological process
- fatty acid biosynthetic process;acyl-CoA metabolic process;xenobiotic metabolic process;energy derivation by oxidation of organic compounds;benzoate metabolic process;fatty acid oxidation;butyrate metabolic process;cholesterol homeostasis
- Cellular component
- mitochondrial matrix;extracellular exosome;blood microparticle
- Molecular function
- acyl-CoA ligase activity;fatty-acyl-CoA synthase activity;ATP binding;GTP binding;fatty acid ligase activity;CoA-ligase activity;metal ion binding;butyrate-CoA ligase activity